Sift

In the complex world of U.S. judicial systems, mass tort claims—lawsuits involving numerous plaintiffs against one or more corporate defendants—are becoming increasingly common. These cases often arise from allegations that products, pharmaceuticals, or other consumer goods have caused widespread harm. As they multiply, courts are challenged with distinguishing meritorious lawsuits from those that are less substantial, a task that is pivotal to maintaining the integrity of the judiciary and ensuring justice for all parties involved. The efficiency of mass tort proceedings can be significantly hampered by the influx of nonmeritorious claims. These are claims that … Read more